Artivion Inc
AORT40.550USD
-0.810-1.96%
收盘 09/19, 16:00（美东）报价延迟15分钟
1.91B总市值
亏损市盈率 TTM
关于 Artivion Inc 公司
Artivion, Inc. 是一家医疗器械公司，从事制造、加工和分销用于治疗主动脉疾病、心脏瓣膜疾病、主动脉瘤和主动脉夹层患者的心脏和血管外科手术的医疗器械和可植入人体组织。该公司的部门包括医疗器械和保存服务。医疗器械部门包括主动脉支架移植物、手术密封剂和 On-X 的销售。保存服务部门包括保存心脏和血管可植入人体组织的服务。该公司有四个产品系列：主动脉支架移植物、手术密封剂、On-X 机械心脏瓣膜和相关手术产品以及可植入心脏和血管人体组织。主动脉支架移植物包括主动脉弓支架移植物、腹部支架移植物和合成血管移植物。手术密封剂包括 BioGlue 手术粘合剂产品。该公司还销售或分销 PhotoFix 牛手术贴片。
公司简介
公司代码AORT
公司名称Artivion Inc
上市日期Feb 12, 1993
CEOMr. James Patrick (Pat) Mackin
员工数量1600
证券类型Ordinary Share
年结日Feb 12
公司地址1655 Roberts Boulevard N W
城市KENNESAW
上市交易所NYSE Consolidated
国家United States of America
邮编30144
电话17704193355
网址https://artivion.com/
公司代码AORT
上市日期Feb 12, 1993
CEOMr. James Patrick (Pat) Mackin
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
188.49K
--
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
+4.40%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
+4.41%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
142.38K
--
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
+5.12%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
121.36K
+10.09%
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
68.65K
+10.15%
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
53.80K
+13.32%
Dr. Marshall S. Stanton, M.D.
Dr. Marshall S. Stanton, M.D.
Senior Vice President, Clinical Research and Chief Medical Officer
Senior Vice President, Clinical Research and Chief Medical Officer
48.71K
--
Mr. Matthew A. (Matt) Getz
Mr. Matthew A. (Matt) Getz
Vice President - Human Resources
Vice President - Human Resources
34.12K
-21.64%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
188.49K
--
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
+4.40%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
+4.41%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
142.38K
--
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
+5.12%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
121.36K
+10.09%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Aortic stent grafts
36.60M
36.98%
On X
21.57M
21.80%
Surgical sealants
18.11M
18.29%
Other
2.52M
2.54%
暂无数据
业务
地区
业务USD
名称
营收
占比
Aortic stent grafts
36.60M
36.98%
On X
21.57M
21.80%
Surgical sealants
18.11M
18.29%
Other
2.52M
2.54%
股东统计
更新时间: 8月17日 周日
更新时间: 8月17日 周日
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
11.75%
Macquarie Investment Management
6.27%
Perceptive Advisors LLC
5.92%
The Vanguard Group, Inc.
5.91%
Fidelity Management & Research Company LLC
4.66%
其他
65.50%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
11.75%
Macquarie Investment Management
6.27%
Perceptive Advisors LLC
5.92%
The Vanguard Group, Inc.
5.91%
Fidelity Management & Research Company LLC
4.66%
其他
65.50%
股东类型
持股股东
占比
Investment Advisor
50.47%
Investment Advisor/Hedge Fund
27.96%
Private Equity
5.92%
Individual Investor
4.71%
Hedge Fund
2.80%
Research Firm
1.28%
Pension Fund
0.94%
Bank and Trust
0.38%
Venture Capital
0.11%
其他
5.44%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
391
44.35M
103.59%
+1.98M
2025Q1
402
44.36M
103.89%
+1.66M
2024Q4
380
41.09M
97.75%
+880.04K
2024Q3
367
38.98M
93.02%
-790.24K
2024Q2
349
38.52M
92.17%
-784.32K
2024Q1
347
38.26M
91.68%
-2.02M
2023Q4
342
37.08M
90.20%
-1.57M
2023Q3
339
37.01M
90.02%
-1.95M
2023Q2
331
37.22M
87.77%
-1.77M
2023Q1
335
37.61M
88.87%
-1.51M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
5.75M
13.46%
-106.89K
-1.83%
Mar 31, 2025
Macquarie Investment Management
2.90M
6.8%
+166.78K
+6.09%
Mar 31, 2025
Perceptive Advisors LLC
2.79M
6.54%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
2.77M
6.49%
-22.88K
-0.82%
Mar 31, 2025
Fidelity Management & Research Company LLC
2.78M
6.51%
+1.72M
+161.42%
Mar 31, 2025
Morgan Stanley Smith Barney LLC
1.94M
4.54%
-50.93K
-2.56%
Mar 31, 2025
Juniper Investment Company, LLC
2.10M
4.91%
--
--
Mar 31, 2025
Wellington Management Company, LLP
1.73M
4.05%
+67.33K
+4.06%
Mar 31, 2025
State Street Global Advisors (US)
1.53M
3.59%
-13.74K
-0.89%
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
